156 related articles for article (PubMed ID: 38769521)
1. Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma.
Li J; Wang W; Li S; Qiao Z; Jiang H; Chang X; Zhu Y; Tan H; Ma X; Dong Y; He Z; Wang Z; Liu Q; Yao S; Yang C; Yang M; Cao L; Zhang J; Li W; Wang W; Yang Z; Rong P
Cancer Cell Int; 2024 May; 24(1):176. PubMed ID: 38769521
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB.
Xue Y; Chen C; Xu W; Xu H; Zheng J; Gu Y
Oncol Lett; 2018 May; 15(5):7693-7701. PubMed ID: 29731900
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
[TBL] [Abstract][Full Text] [Related]
6. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
7. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
9. FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.
Shi JY; Ma LJ; Zhang JW; Duan M; Ding ZB; Yang LX; Cao Y; Zhou J; Fan J; Zhang X; Zhao YJ; Wang XY; Gao Q
BMC Cancer; 2017 Sep; 17(1):648. PubMed ID: 28903735
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
Cai H; Guo F; Wen S; Jin X; Wu H; Ren D
J Exp Clin Cancer Res; 2022 Feb; 41(1):73. PubMed ID: 35193647
[TBL] [Abstract][Full Text] [Related]
12. Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules.
Zhang YB; Bao YR; Wang S; Li TJ; Tai H; Leng JP; Yang XX; Wang BC; Meng XS
World J Gastrointest Oncol; 2023 Mar; 15(3):504-522. PubMed ID: 37009316
[TBL] [Abstract][Full Text] [Related]
13. KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma.
Dai Z; Huang Q; Huang X; Zhu C; Zahid KR; Liu T; Li Q; Wu C; Peng M; Xiao X; Raza U; Yu N; Zeng T
Mol Carcinog; 2023 Mar; 62(3):369-384. PubMed ID: 36468848
[TBL] [Abstract][Full Text] [Related]
14. miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation.
Li Y; Wu B; Sun R; Zhao M; Li N
Autoimmunity; 2021 Dec; 54(8):547-560. PubMed ID: 34435526
[TBL] [Abstract][Full Text] [Related]
15. FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma
Zhao K; Gao J; Shi J; Shi C; Pang C; Li J; Guo W; Zhang S
Oncol Lett; 2023 Jan; 25(1):22. PubMed ID: 36466996
[TBL] [Abstract][Full Text] [Related]
16. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
[TBL] [Abstract][Full Text] [Related]
17. CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20.
Li F; Liu CS; Wu P; Ling AS; Pan Q; Li XN
Chin Med J (Engl); 2021 Nov; 134(22):2721-2729. PubMed ID: 34732665
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
19. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
